Dr. Michael Lim, MD

Dr. Lim practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Lim's NPI, 1225240286, was assigned on May 3, 2007. Dr. Lim graduated from The Johns Hopkins University School of Medicine in 2000. Dr. Lim holds California license A76130.

Dr. Lim's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Lim's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. Lim to 1 more hospital and 2 medical groups, each named with a free account. Dr. Lim's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lim practices, 2 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Lim's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Lim is board certified in neurological surgery by the American Board of Neurological Surgery. Dmand AI has Dr. Lim's licenses on file in 8 states: California, Nevada, Alaska, Maryland, Texas, Kansas, Oregon and North Carolina.

Dmand AI lists craniotomy among the conditions Dr. Lim treats.

CMS data shows 285 Medicare services from Dr. Lim across 7 procedure codes in 2024, for 160 Medicare patients. Medicare paid $110,606 for them.

CMS counts 160 Medicare patients who saw Dr. Lim in 2024. The largest group is 65 to 74, with 82 patients. 74% of them have high cholesterol, and 64% have high blood pressure. 14% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lim's median patient age at 58, with 69% women.

In 2019, Dr. Lim wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $284 in total drug cost. In 2017, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Lim for performance year 2024, reported as part of a group. Dr. Lim accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lim as offering telehealth.

Dmand AI links 298 papers to Dr. Lim, published from 2004 to 2025. 2023 was the busiest year, with 22. The most frequent topics are Brain Neoplasms, Glioblastoma and Immunotherapy. Dr. Lim has published most often in J Neurosurg. Dr. Lim's most frequent co-authors are Chetan Bettegowda, MD, PhD, Christopher Mitchell Jackson, MD and Lawrence Kleinberg, MD.

Dmand AI links Dr. Lim to 6 clinical trials, 3 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Chordoma, Gliosarcoma and Neoplasm Metastasis. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins sponsors the most, 4. Open Payments lists research payments to Dr. Lim that name 1 trial.

CMS Open Payments shows 474 general payments to Dr. Lim from 27 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 63% of the total. Stryker Corporation paid the most, $299,255. It also lists 1 research payment totaling $2,700 in 2017, naming 1 clinical trial.

Dmand AI lists 2 awards for Dr. Lim, most recently CMS Stage 1 EHR in 2014.

Dr. Lim graduated from The Johns Hopkins University School of Medicine in 2000. Dr. Lim is a member of AANS and CNS.

Dr. Lim is in network with 9 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.